Diuril Suspension
Product Images NDC 65649-311

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diuril (NDC 65649-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Salix Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton

DIURIL (chlorothiazide) Oral Suspension 250 mg per 5 mL (50 mg/mL) in a 237 mL bottle, labeled as RX only. Distributed by Salix Pharmaceuticals, Inc., with storage instructions and ingredient details on the label. The label includes dosage warnings, manufacturer information, and barcodes.*

FDA Label Image

Chemical Structure (Diuril 1)

Chemical structure of chlorothiazide, the active ingredient in DIURIL oral suspension 250 mg/5mL. The diagram shows the molecular arrangement with a benzene ring, sulfonamide group, chlorine atom, and other functional groups characteristic of chlorothiazide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.